We are glad to announce that a new product API Bortezomib is coming to our portfolio. The product development is supported by Enterprise Estonia and European Union Regional Development Fund as a part of the project EU42410 „Development and application of Bortezomib synthesis technologies“.

The project started in February 2012 and will last till February 2015.